Edwin Torr
Director/Board Member at ANIMALCARE GROUP PLC
Net worth: 312 156 $ as of 2024-04-29
Profile
Edwin Thomas Torr is currently a Senior Independent Non-Executive Director at Animalcare Group Plc and an Independent Non-Executive Director at Intervacc AB.
Previously, he was the Chairman of Agrimin Ltd.
and held positions at Dechra Pharmaceuticals Plc and Dechra Veterinary Products Ltd., including Director of Business Development and Managing Director, respectively.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ANIMALCARE GROUP PLC
0.18% | 2022-12-30 | 107,455 ( 0.18% ) | 312 156 $ | 2024-04-29 |
Edwin Torr active positions
Companies | Position | Start |
---|---|---|
ANIMALCARE GROUP PLC | Director/Board Member | 2017-07-12 |
INTERVACC AB | Director/Board Member | 2020-02-29 |
Former positions of Edwin Torr
Companies | Position | End |
---|---|---|
DECHRA PHARMACEUTICALS | Director/Board Member | 2012-12-31 |
Dechra Veterinary Products Ltd.
Dechra Veterinary Products Ltd. Pharmaceuticals: MajorHealth Technology Dechra Veterinary Products Ltd. engages in the development of branded pharmaceuticals for companion animals. The company is headquartered in Shrewsbury, the United Kingdom. | Chief Executive Officer | 2000-08-31 |
AGRIMIN LIMITED | Chairman | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
ANIMALCARE GROUP PLC | Health Technology |
INTERVACC AB | Health Technology |
AGRIMIN LIMITED | Non-Energy Minerals |
Private companies | 2 |
---|---|
Dechra Pharmaceuticals Plc
Dechra Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Dechra Pharmaceuticals Ltd. is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe. The North American Pharmaceuticals segment focuses on the sale of a range of endocrine, ophthalmic, dermatological, and equine products in North America. The Pharmaceuticals Research and Development segment develops and licenses Dechra's own branded veterinary product portfolio of novel and generic pharmaceuticals and specialist pet diets. The company was founded in 1819 and is headquartered in Northwich, the United Kingdom. | Health Technology |
Dechra Veterinary Products Ltd.
Dechra Veterinary Products Ltd. Pharmaceuticals: MajorHealth Technology Dechra Veterinary Products Ltd. engages in the development of branded pharmaceuticals for companion animals. The company is headquartered in Shrewsbury, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Edwin Torr